RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides With Positive ANCA After Relapse or Resistant Immunosuppressant Therapies InfliximabVersus Rituximab in Systemic Necrotizing Vasculitides With Positive ANCA After Relapse or ...